Nautilus Biotechnolgy, Inc. (NAUT)
$0.88-7.37%Close
SELLCRISIS · day 41
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $112M
- Avg volume
- 700.2K
- Beta
- 0.87
- P/E (TTM)
- -1.95
- Short % float
- 4.07%
- Days to cover
- 2.7
- SI change
- +56.9%
- 1W
- +0.00%
- 1M
- -47.93%
- 3M
- -65.35%
- YTD
- -53.93%
- vs SPY 1W
- +1.19%
- vs SPY 1M
- -51.25%
- vs SPY 3M
- -67.75%
- vs SPY YTD
- -65.68%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
